Calliditas Therapeutics AB (CALT)

NASDAQ: CALT · Delayed Price · USD
18.99
-0.56 (-2.86%)
At close: Jan 26, 2022 4:00 PM
19.80
0.81 (4.27%)
Pre-market:Jan 27, 2022 5:12 AM EST

Income Statement (Annual)

Millions SEK. Fiscal year is Jan - Dec.
Year202020192018
Revenue
0.87184.830
Revenue Growth (YoY)
-99.53%--
Gross Profit
0.87184.830
Selling, General & Admin
141.7262.8831.13
Research & Development
241.37149.8399.26
Other Operating Expenses
-2.50.142.09
Operating Expenses
380.59212.85132.48
Operating Income
-379.72-28.02-132.48
Interest Expense / Income
56.985.410.01
Other Expense / Income
-3.56-0.93-0.44
Pretax Income
-433.13-32.5-132.05
Income Tax
0.360.080
Net Income
-433.49-32.58-132.05
Net Income Common
-433.49-32.58-132.05
Shares Outstanding (Basic)
4646-
EPS (Basic)
-19.32-1.76-10.18
EPS (Diluted)
-19.32-1.76-10.18
Free Cash Flow Per Share
-13.36-3.07-
Gross Margin
100.00%100.00%-
Operating Margin
-43446.22%-15.16%-
Profit Margin
-49598.86%-17.63%-
Free Cash Flow Margin
-35375.40%-38.48%-
Effective Tax Rate
-0.08%-0.24%0.00%
EBITDA
-376.16-27.09-132.04
EBITDA Margin
-43038.44%-14.66%-
EBIT
-376.16-27.09-132.04
EBIT Margin
-43038.44%-14.66%-
Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).